Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Salles
    Salles
  9. Horwitz
    Horwitz
  10. Perales
    Perales

Groups

  1. Department of Medicine (296)
  2. Hematologic Malignancies, Division of (295)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (44)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (124)
  3. Research Letter (26)
  4. Editorial (17)
  5. Review (12)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (296)
  2. Hematologic Malignancies, Division of (295)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (19)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (355)
  2. Haematologica Meeting Reports (4)

Results (359)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia
    Journal Article

    Brunstein, C.; Zhang, M. J.; Barker, J.; St. Martin, A.; Bashey, A.; De Lima, M.; Dehn, J.; Hematti, P.; Perales, M. A.; Rocha, V.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
    Journal Article

    Engelhardt, M.; Domm, A. S.; Dold, S. M.; Ihorst, G.; Reinhardt, H.; Zober, A.; Hieke, S.; Baayen, C.; Müller, S. J.; Einsele, H.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Nivolumab re-treatment in patients with relapsed/refractory Hodgkin lymphoma: Safety and efficacy outcomes from a phase 1 clinical trial
    Meeting Abstract

    Ansell, S.; Armand, P.; Timmerman, J.; Shipp, M.; Popa McKiver, M.; Zhu, L.; Lesokhin, A. M.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin after autologous stem cell transplant yields the strongest benefit in Hodgkin lymphoma patients with ≥2 risk factors: Results of a multivariate analysis
    Meeting Abstract

    Moskowitz, C.; Sweetenham, J.; Chen, A.; Ayala, E.; Masszi, T.; Holowiecki, J.; Stiff, P.; Carella, A.; Viviani, S.; Bachanova, V.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Results of US Intergroup trial of response-adapted chemotherapy or chemotherapy/radiation therapy based on PET for non-bulky stage I and II Hodgkin lymphoma (CALGB/Alliance 50604)
    Meeting Abstract

    Straus, D.; Pitcher, B.; Kostakoglu, L.; Grecula, J. C.; Hsi, E. D.; Schöder, H.; Jung, S. H.; Popplewell, L.; Chang, J. E.; Moskowitz, C.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Residual site radiation therapy: An opportunity to increase safety of combined modality therapy for early stage Hodgkin lymphoma
    Meeting Abstract

    Straus, D.; Cahlon, O.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Sequential brentuximab vedotin and adriamycin, vinblastine, and dacarbazine for older patients with untreated Hodgkin lymphoma: Findings from a phase II Window study
    Meeting Abstract

    Evens, A. M.; Hamlin, P. A.; Nabhan, C.; Advani, R.; Fanale, M.; Petrich, A.; Smith, S.; Bociek, G.; Winter, J.; Gordon, L. I.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Evaluation of serum TARC levels in patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma: Results from the AETHERA trial
    Meeting Abstract

    Bachanova, V.; Carella, A.; Masszi, T.; Holowiecki, J.; Viviani, S.; Huebner, D.; Hunder, N.; Larsen, E.; Odegard, J.; Onsum, M.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • CHIPS as a predictor of outcome in radiated vs unradiated HL
    Meeting Abstract

    Schwartz, C. L.; Wolden, S.; Constine, L. S.; Chen, L.; Friedman, D.
    Haematologica (2016)

    Fulltext@MSK | Save
  • CheckMate 205 Cohort C: Nivolumab in patients with classical Hodgkin lymphoma after prior brentuximab vedotin and autologous hematopoietic stem cell transplantation
    Meeting Abstract

    Zinzani, P. L.; Engert, A.; Younes, A.; Santoro, A.; Ansell, S.; Timmerman, J.; Collins, G.; Armand, P.; Savage, K. J.; Trneny, M.; more...
    Haematologica (2016)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: